Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation (RENAL-AF)

Clinical Trial ID NCT02942407

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02942407

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011 23.50
2 Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007 10.87
3 Apixaban in patients with atrial fibrillation. N Engl J Med 2011 9.97
4 Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med 2012 4.69
5 Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk. Stat Med 1990 4.43
6 Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis. Circulation 2014 3.78
7 Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2011 3.48
8 Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. J Am Soc Nephrol 2009 3.40
9 Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial. Eur Heart J 2012 2.94
10 Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial. Eur Heart J 2014 2.32
11 Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment. Eur Heart J 2011 2.31
12 Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy. Kidney Int 2010 2.10
13 Warfarin anticoagulation in hemodialysis patients: a systematic review of bleeding rates. Am J Kidney Dis 2007 1.70
14 Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation. Clin J Am Soc Nephrol 2011 1.67
15 Warfarin in haemodialysis patients with atrial fibrillation: what benefit? Europace 2010 1.49
16 A single-item self-report medication adherence question predicts hospitalisation and death in patients with heart failure. J Clin Nurs 2013 1.48
17 Dilemmas in the management of atrial fibrillation in chronic kidney disease. J Am Soc Nephrol 2008 1.30
18 Validity of medication adherence self-reports in adults with type 2 diabetes. Diabetes Care 2012 1.16
19 Warfarin in atrial fibrillation patients with moderate chronic kidney disease. Clin J Am Soc Nephrol 2011 1.15
20 Statin use and calcific uremic arteriolopathy: a matched case-control study. Am J Nephrol 2013 1.04
21 Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis. Circulation 2015 1.02
22 A pint of sweat will save a gallon of blood: a call for randomized trials of anticoagulation in end-stage renal disease. Circulation 2014 0.78
Next 100